Skip to main content

Peer Review reports

From: Efficacy and safety of ambrisentan in Chinese patients with connective tissue disease-pulmonary arterial hypertension: a post-hoc analysis

Original Submission
29 May 2019 Submitted Original manuscript
26 Nov 2019 Author responded Author comments - Mengtao Li
21 Jun 2019 Reviewed Reviewer Report - Hyung-Kwan Kim
2 Jul 2019 Reviewed Reviewer Report
Resubmission - Version 2
26 Nov 2019 Submitted Manuscript version 2
7 May 2020 Author responded Author comments - Mengtao Li
28 Dec 2019 Reviewed Reviewer Report
19 Jan 2020 Reviewed Reviewer Report
Resubmission - Version 3
7 May 2020 Submitted Manuscript version 3
15 Jun 2020 Author responded Author comments - Mengtao Li
23 May 2020 Reviewed Reviewer Report
12 May 2020 Reviewed Reviewer Report
Resubmission - Version 4
15 Jun 2020 Submitted Manuscript version 4
Publishing
16 Jun 2020 Editorially accepted
17 Jul 2020 Article published 10.1186/s12872-020-01591-1

You can find further information about peer review here.

Back to article page
\